Answers are grounded in this paper and cite their sources.
Prostaglandin (PG)D2 is produced and/or triggered by different parasites to modulate the course of the infection. These findings position PGD2 as a therapeutic target and suggest potential beneficial effects of repositioned drugs that target its synthesis or receptor engagement. However, recent in vivo data may suggest a more nuanced role and warrants further investigation of the role of PGD2 during the full course and complexity of parasitic infections.
No takes yet. Share an insight, caveat, or question.
Diaz et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: